Cherry JDPertussis — the trials and tribulations of old and new pertussis vaccines . Vaccine1992; 10: 1033—1038.
2.
Cherry JDHistorical review of pertussis and the classical vaccine. J Infect Dis1996; 174: S259—S263.
3.
Heininger U., Stehr K., Schmittgrohe S. et al. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J1994; 13: 306—309.
4.
Pichichero ME , Treanor J.Economic impact of pertussis. Arch Pediatr Adolesc Med1997; 151: 35—40.
5.
Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BHPrevalence and incidence of adult pertussis in an urban-population. JAMA1996; 275: 1672—1674.
6.
Porter JF, Connor K., Donachie W.Isolation and characterization of Bordetella parapertussis-like bacteria from ovine lungs. Microbiol UK1994; 140: 255—261.
7.
Porter JF, Connor K., Donachie W.Differentiation between human and ovine isolates of Bordetella parapertussis using pulsed-field gel-electrophoresis. FEMS Microbiol Lett1996; 135: 131—135.
8.
Porter JF, Connor K., Vanderzee A. et al. Characterization of ovine Bordetella parapertussis isolates by analysis of specific endotoxin (lipopolysaccharide) epitopes, filamentous hemagglutinin production, cellular fatty-acid composition and antibiotic-sensitivity . FEMS Microbiol Lett1995; 132: 195—201.
9.
van der Zee A., Mooi F., Van Embden J., Musser J.Molecular evolution and host adaptation of Bordetella spp.: phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences. J Bacteriol1997; 179: 6609—6617.
10.
Burns Jr EH , Norman JM, Hatcher MD, Bemis DAFimbriae and determination of host species specificity of Bordetella bronchiseptica. J Clin Microbiol1993; 31: 1838—1844.
11.
Rutter JMQuantitative observations on Bordetella bronchiseptica infection in atrophic rhinitis of pigs. Vet Rec1981; 108: 451—454.
12.
Thrusfield MV, Aitken Cgg, Muirhead RHA field investigation of kennel cough — efficacy of different treatments. J Small Anim Pract1991; 32: 455—459.
13.
Thrusfield MV, Aitken Cgg, Muirhead RHA field investigation of kennel cough — incubation period and clinical signs. J Small Anim Pract1991; 32: 215—220.
14.
Reina J., Bassa A., Llompart I., Borrell N., Gomez J., Serra A.Pneumonia caused by Bordetella bronchiseptica in a patient with a thoracic trauma. Infection1991; 19: 46—48.
15.
Gueirard P. , Weber C, Lecoustumier A, Guiso N. Human Bordetella bronchiseptica infection related to contact with infected animals — persistence of bacteria in host. J Clin Microbiol1995; 33: 2002—2006.
16.
Tamion F., Girault C., Chevron V., Pestel M., Bonmarchand G.Bordetella bronchiseptica pneumonia with shock in an immunocompetent patient . Scand J Infect Dis1996; 28: 197—198.
17.
Stibitz S., Aaronson W., Monack D., Falkow S.Phase variation in Bordetella pertussis by frameshift mutation in a gene for a novel two-component system. Nature1989; 338: 266—269.
18.
van der Zee A., Mooi F., van Embden J., Musser J.Molecular evolution and host adaptation of Bordetella spp.: phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences. J Bacteriol1997; 179: 6609—6617.
19.
Skeeles JK, Arp LHBordetellosis (turkey coryza). In: Calnek BW, Barnes HJ, Beard CW, McDougal LR, Saif YM. (eds) Diseases of Poultry. Ames, IA: Iowa State University Press, 1997; 275—288.
20.
Cookson BT, Vandamme P., Carlson LC et al. Bacteremia caused by a novel Bordetella species, `B. hinzii '. J Clin Microbiol1994; 32: 2569—2571.
21.
Funke G., Hess T., von Graevenitz A., Vandamme P.Characteristics of Bordetella hinzii strains isolated from a cystic fibrosis patient over a 3-year period. J Clin Microbiol1996; 34: 966—969.
22.
Vandamme P. , Hommez J., Vancanneyt M. et al. Bordetella hinzii sp-nov, isolated from poultry and humans. Int J Syst Bacteriol1995; 45: 37-45.
23.
Vandamme P. , Heyndrickx M., Vancanneyt M. et al. Bordetella trematum sp nov, isolated from wounds and ear infections in humans, and reassessment of Alcaligenes denitrificans Ruger and Tan 1983. Int J Syst Bacteriol1996; 46: 849—858.
Weyant RS, Hollis DG, Weaver RE et al. Bordetella holmesii sp. nov., a new Gram-negative species associated with septicemia. J Clin Microbiol1995; 33: 1—7.
26.
Hewlett ELPertussis: current concepts of pathogenesis and prevention. Pediatr Infect Dis J1997; 16: S78—S84.
27.
Cotter PA, Miller JFBordetella. In: Groisman E. (ed) Principles of Bacterial Pathogenesis. San Diego, CA: Academic Press, 2001; 619—74.
28.
Flak TA, Heiss LN, Engle JT, Goldman WESynergistic epithelial responses to endotoxin and a naturally occurring muramyl peptide. Infect Immun2000; 68: 1235—1242.
29.
Boschwitz JS , Batanghari JW, Kedem H., Relman DABordetella pertussis infection of human monocytes inhibits antigen-dependent CD4 T cell proliferation. J Infect Dis1997; 176: 678—686.
30.
Ewanowich CA , Melton AR, Weiss AA, Sherburne RK, Peppler MSInvasion of HeLa 229 cells by virulent Bordetella pertussis. Infect Immun1989; 57: 2698—2704.
31.
Ewanowich CA , Sherburne RK, Man SF, Peppler MSBordetella parapertussis invasion of HeLa 229 cells and human respiratory epithelial cells in primary culture. Infect Immun1989; 57: 1240—1247.
32.
Guzman CA, Rohde M., Bock M., Timmis KNInvasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells. Infect Immun1994; 62: 5528—5537.
33.
Guzman CA, Rohde M., Timmis KNMechanisms involved in uptake of Bordetella bronchiseptica by mouse dendritic cells. Infect Immun1994; 62: 5538—5544.
34.
Bromberg K. , Tannis G., Steiner P.Detection of Bordetella pertussis associated with the alveolar macrophages of children with human-immunodeficiency-virus infection. Infect Immun1991; 59: 4715—4719.
35.
Mills KH, Brady M., Ryan E., Mahon BPA respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity. Dev Biol Stand1998 ; 95: 31—41.
36.
Ryan M., Murphy G., Ryan E. et al. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology1998; 93: 1—10.
Yuk MH, Harvill ET, Miller JFThe BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica. Mol Microbiol1998; 28: 945—959.
39.
Amano K., Fukushi K., Watanabe M.Biochemical and immunological comparison of lipopolysaccharides from Bordetella species. J Gen Microbiol1990; 136: 481—487.
40.
Chaby R., Caroff M.Lipopolysaccharide of Bordetella pertussis endotoxin. In: Wardlaw AC, Parton R. (eds) Pathogenesis and Immunity in Pertussis. New York, NY: John Wiley, 1988; 247—271.
41.
Watanabe M. , Takimoto H., Kumazawa Y., Amano K.Biological properties of lipopolysaccharides from Bordetella species. J Gen Microbiol1990 ; 136: 489—493.
42.
Shahin RD, Hamel J., Leef MF, Brodeur BRAnalysis of protective and non-protective monoclonal-antibodies specific for Bordetella pertussis lipooligosaccharide. Infect Immun1994; 62: 722—725.
43.
Caroff M., Chaby R., Karibian D., Perry J., Deprun C., Szabo L.Variations in the carbohydrate regions of Bordetella pertussis lipopolysaccharides: electrophoretic, serological, and structural features. J Bacteriol1990; 172: 1121—1128.
44.
Caroff M., Aussel L., Zarrouk H. et al. In: 6th International Endotoxin Society Conference , Paris, 2000.
45.
Zarrouk H., Karibian D., Bodie S., Perry MB, Richards JC, Caroff M.Structural characterization of the lipids A of three Bordetella bronchiseptica strains: variability of fatty acid substitution. J Bacteriol1997; 179: 3756—3760.
46.
Aussel L., Brisson JR, Perry MB, Caroff M.Structure of the lipid A of Bordetella hinzii ATCC 51730. Rapid Commun Mass Spectrom2000; 14: 595—599.
47.
Peppler MSTwo physically and serologically distinct lipopolysaccharide profiles in strains of Bordetella pertussis and their phenotype variants. Infect Immun1984; 43: 224—232.
48.
Caroff M., Brisson J., Martin A., Karibian D.Structure of the Bordetella pertussis 1414 endotoxin. FEBS Lett2000; 477: 8—14.
49.
Vinogradov E.The structure of the carbohydrate backbone of the lipopolysaccharides from Bordetella hinzii and Bordetella bronchiseptica . Eur J Biochem2000; 267: 4577—4582.
50.
Preston A., Allen AG, Cadisch J. et al. Genetic basis for lipopolysaccharide O-antigen biosynthesis in Bordetellae. Infect Immun1999; 67: 3763—3767.
51.
Di Fabio JL , Caroff M., Karibian D., Richards JC, Perry MBCharacterization of the common antigenic lipopolysaccharide O-chains produced by Bordetella bronchiseptica and Bordetella parapertussis . FEMS Microbiol Lett1992; 76: 275—281.
52.
Vinogradov E., Peppler MS, Perry MBThe structure of the nonreducing terminal groups in the O-specific polysaccharides from two strains of Bordetella bronchiseptica . Eur J Biochem2000; 267: 7230—7237.
53.
Aussel L., Chaby R., Le Blay K. et al. Chemical and serological characterization of the Bordetella hinzii lipopolysaccharides(1). FEBS Lett2000 ; 485: 40—46.
54.
Schnaitman CA, Klena JDGenetics of lipopolysaccharide biosynthesis in enteric bacteria. Microbiol Rev1993; 57: 655—682.
55.
Crowell DN, Anderson MS, Raetz CRMolecular cloning of the genes for lipid A disaccharide synthase and UDP-N-acetylglucosamine acyltransferase in Escherichia coli. J Bacteriol1986; 168: 152—159.
56.
Coleman J., Raetz CRFirst committed step of lipid A biosynthesis in Escherichia coli: sequence of the lpxA gene. J Bacteriol1988; 170: 1268—1274.
57.
Rick PD, Raetz Crh.Microbial pathways of Lipid A biosynthesis. In: Brade H, Opal SM, Vogel SN, Morrison DC. (eds) Endotoxin in Health and Disease. New York, NY: Marcel Dekker, 1999; 283—304.
58.
Wyckoff TJ, Lin S., Cotter RJ, Dotson GD, Raetz CRHydrocarbon rulers in UDP-N-acetylglucosamine. J Biol Chem1998; 273: 32369—32372.
59.
Allen A., Maskell D.The identification, cloning and mutagenesis of a genetic locus required for lipopolysaccharide biosynthesis in Bordetella pertussis. Mol Microbiol1996; 19: 37—52.
60.
Allen AG, Isobe T., Maskell DJIdentification and cloning of waaF (rfaF) from Bordetella pertussis and use to generate mutants of Bordetella spp. with deep rough lipopolysaccharide . J Bacteriol1998; 180: 35—40.
61.
Isobe T., White KA, Allen AG, Peacock M., Raetz CR, Maskell DJBordetella pertussis waaA encodes a monofunctional 2-keto-3- deoxy-D-manno-octulosonic acid transferase that can complement an Escherichia coli waaA mutation. J Bacteriol1999; 181: 2648—2651.
62.
Zhou Z., White KA, Polissi A., Georgopoulos C., Raetz CRFunction of Escherichia coli MsbA, an essential ABC family transporter, in lipid A and phospholipid biosynthesis. J Biol Chem1998; 273: 12466—12475.
63.
West NP, Jungnitz H., Fitter JT, McArthur JD, Guzman CA, Walker MJRole of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence. Infect Immun2000 ; 68: 4673—4680.
64.
Belanger M. , Burrows LL, Lam JSFunctional analysis of genes responsible for the synthesis of the B-band O antigen of Pseudomonas aeruginosa serotype O6 lipopolysaccharide. Microbiol UK1999; 145: 3505—3521.
65.
Allen AG, Thomas RM, Cadisch JT, Maskell DJMolecular and functional analysis of the lipopolysaccharide biosynthesis locus wlb from Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Mol Microbiol1998; 29: 27—38.
66.
Spears PA, Temple LM, Orndorff PEA role for lipopolysaccharide in turkey tracheal colonization by Bordetella avium as demonstrated in vivo and in vitro. Mol Microbiol2000; 36: 1425—1435.
67.
Whitfield C.Biosynthesis of lipopolysaccharide O antigens . Trends Microbiol1995; 3: 178—185.
68.
Cotter PA, Miller JFA mutation in the Bordetella bronchiseptica bvgS gene results in reduced virulence and increased resistance to starvation, and identifies a new class of Bvg-regulated antigens. Mol Microbiol1997; 24: 671—685.
69.
van denAkker WMLipopolysaccharide expression within the genus Bordetella: influence of temperature and phase variation. Microbiol UK1998; 144: 1527—1535.
70.
Gunn JS, Lim KB, Krueger R. et al. PmrA-pmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol1998; 27: 1171—1182.
71.
Banemann A. , Deppisch H., Gross R.The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides. Infect Immun1998; 66: 5607—5612.
72.
Turcotte ML , Martin D., Brodeur BR, Peppler MSTn5-induced lipopolysaccharide mutations in Bordetella pertussis that affect outer membrane function. Microbiology UK1997; 143: 2381—2394.
73.
Flak TA, Goldman WESignalling and cellular specificity of airway nitric oxide production in pertussis . Cell Microbiol1999; 1: 51—60.
74.
Harvill ET, Preston A., Cotter PA, Allen AG, Maskell DJ, Miller JFMultiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection. Infect Immun2000; 68: 6720—6728.